drugset
Drugs / V7
last change Dec 2018 re-read 3 minutes ago

V7

also known as V7 or tableted heat-inactivated mycobacterium vaccae

Vaccine

Developed for
tuberculosis
Investigated by
Immunitor USA Inc. · Lisichansk Regional Tuberculosis Dispensary · National Medical University, Ukraine · Immunitor LLC · University of Stellenbosch

Trials 2

today NCT01977768 · Ph 3 NCT01380119 · Ph 2
2012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 21 trial
Phase 2 NCT01380119 Aug 2011 → Aug 2012 tuberculosis Lisichansk Regional Tuberculosis Dispensary Completed No outcome recorded
Phase 31 trial
Phase 3 NCT01977768 Mar 2014 → Oct 2018 tuberculosis Immunitor LLC Completed No outcome recorded

Evidence & citations 4 cited values

Every value below carries the sentence it was read from. 3 sources stand behind the page.

FieldValueCited text
Known as V7 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01380119 ↗
1

NCT01977768 ↗
Known as V7 or tableted heat-inactivated mycobacterium vaccae “V7 or tableted heat-inactivated mycobacterium vaccae” NCT01977768 ↗
Modality Vaccine “therapeutic TB vaccine (V7)” PMID 23782489 ↗ Jun 2013
Route Oral “an orally-administered therapeutic TB vaccine (V7)” PMID 23782489 ↗ Jun 2013